Abstract:BACKGROUND: The effect of large-scale expanded surveillance for methicillin-resistant Staphylococcus aureus (MRSA) on health care-associated MRSA disease is not known.OBJECTIVE: To examine the effect of 2 expanded surveillance interventions on MRSA disease.DESIGN: Observational study comparing rates of MRSA clinical disease during and after hospital admission in 3 consecutive periods: baseline (12 months), MRSA surveillance for all admissions to the intensive care unit (ICU) (12 months), and universal MRSA surveillance for all hospital admissions (21 months).SETTING: A 3-hospital, 850-bed organization with approximately 40,000 annual admissions.INTERVENTION: Polymerase chain reaction-based nasal surveillance for MRSA followed by topical decolonization therapy and contact isolation of patients who tested positive for MRSA.MEASUREMENTS: Poisson and segmented regression models were used to compare prevalence density of hospital-associated clinical MRSA disease (bloodstream, respiratory, urinary tract, and surgical site) in each period. Rates of bloodstream disease with methicillin-susceptible S. aureus were used as a control.RESULTS: The prevalence density of aggregate hospital-associated MRSA disease (all body sites) per 10,000 patient-days at baseline, during ICU surveillance, and during universal surveillance was 8.9 (95% CI, 7.6 to 10.4), 7.4 (CI, 6.1 to 9.0; P = 0.15 compared with baseline), and 3.9 (CI, 3.2 to 4.7; P < 0.001 compared with baseline and ICU surveillance), respectively. During universal surveillance, the prevalence density of MRSA infection at each body site had a statistically significant decrease compared with baseline. The methicillin-susceptible S. aureus bacteremia rate did not statistically significantly change during the 3 periods. In a segmented regression model, the aggregate hospital-associated MRSA disease prevalence density changed by -36.2% (CI, -65.4% to 9.8%; P = 0.17) from baseline to ICU surveillance and by -69.6% (CI, -89.2% to -19.6%]; P = 0.03) from baseline to universal surveillance. During universal surveillance, the MRSA disease rate decreased during hospitalization and in the 30 days after discharge; no further reduction occurred thereafter. Surveillance with clinical cultures would have identified 17.8% of actual MRSA patient-days, and ICU-based surveillance with polymerase chain reaction would have identified 33.3%.LIMITATION: The findings rely on observational data.CONCLUSION: The introduction of universal admission surveillance for MRSA was associated with a large reduction in MRSA disease during admission and 30 days after discharge.

Effect of Targeted Monitoring of Multidrug-Resistance Bacteria Infections

Surveillance of antibiotic resistance in clinical isolates from First Affiliated Hospital of Zhejiang University Medical College in 2009

Countermeasures of Improving the Prevention and Control of MDRO Infection in Primary Hospitals

Multicenter study on effectiveness of intervention in multidrug-resistant organism infection

Use of antibiotics in multi-center ICU and surveillance of multidrug-resistant organisms in China

Analysis of Intervention Effectiveness of Infection Control of Multidrug-Resistant Bacteria Infection in a General Tertiary Hospital

Characteristic of Multidrug Resistant Organisms in Hospital and Community-acquired Infection

Active surveillance of multidrug-resistant organisms in SICU in a general hospital in 2008 and 2011

Mohnarin Report of 2011: Monitoring of Bcterial Resistance Intensive Care Unit

Study on effect of infection control of multidrug-resistant bacteria infections in general hospital

Mohnarin Report of 2010 :Surveillance of Bacterial Resistance of Non-Icu Inpatients

Monitoring and Control of Pan-Drug Resistant Acinetobacter Baumannii Colonization and Infection in a Medical Intensive Care Unit

Correlation between compliance of control of multidrug-resistant organisms and nosocomial infections in 46 hospitals

Mohnarin report of 2011:monitoring of bacterial resistance of non-ICU inpatients

Control efficacy of hospital-acquired multidrug-resistant organism infections in a surgical intensive care unit

First multicenter study on multidrug resistant bacteria carriage in Chinese ICUs

Mohnarin Report of 2010:Monitoring of Bacterial Resistance in Intensive Care Units

Contamination of ward environment of patients with multidrug-resistant organism infection in a stomatology hospital

Effect of interventions in extended-spectrum β-lactamase-producing Escherichia coliinfections

Universal Surveillance for Methicillin-Resistant Staphylococcus aureus in 3 Affiliated Hospitals

Investigation and analysis of hospital-acquired infections caused by multi-drug resistant organisms in a general hospital